🚨 Loading... Read More

Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

Political Leaning Analysis
Left Center Right
Score: 0.26Center / Neutral

President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already designated as breakthrough therapy drugs."



Different Perspectives

The Hill
1 article
Washington Examiner
1 article